(58 days)
Not Found
No
The 510(k) summary describes a physical, water-soluble implant material and does not mention any software, algorithms, or data processing capabilities that would indicate the use of AI or ML.
No
Explanation: The device description states it is a "water-soluble implant material and as a water-soluble space occupying material as an adjunct during the natural healing process". While it assists healing, its primary function is as a material for implantation and space occupation, not as a device directly providing therapy.
No
The device is described as an "implant material" and "space occupying material" used during the healing process, not for diagnosing conditions.
No
The device description clearly states that Adaptain™ is a physical, water-soluble, wax-like surgical implant material supplied in various forms (bars, sticks, granules, sheets). It is a tangible product, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states it's a "water-soluble implant material and as a water-soluble space occupying material as an adjunct during the natural healing process." This describes a device used within the body to support healing, not a device used to test samples outside the body to diagnose conditions.
- Device Description: The description details a "surgical implant material" that is "water-soluble, wax-like" and "adhere[s] to itself." This further reinforces its use as an implant within the body.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting analytes, or providing diagnostic information.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. Adaptain™ does not fit this description.
N/A
Intended Use / Indications for Use
Adaptain™ is indicated for use as a water-soluble implant material and as a water-soluble space occupying material as an adjunct during the natural healing process.
Product codes
KHJ
Device Description
Adaptain™ is a water-soluble, wax-like surgical implant material that will adhere to itself utilized directly and a first application of firm pressure. Adaptain " is designed to be utilized directly out of the package. The implant will soften as it is warmed. The surface of the implant becomes lubricious when wet, and the implant does not swell as it dissolves.
Adaptain™ is comprised of a sterile mixture of water-soluble alkylene oxide copolymers (AOC PolymerBlend™) and contains no other additives or colorants. Adaptain is supplied in a number of forms including bars, sticks, granules and sheets of various sizes with weights ranging from 0.5 to 5 grams each.
Adaptain™ is provided sterile by irradiation and must not be resterilized.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The non-clinical evaluations used to determine substantial equi valence included indications, intended use, design, materials, sterilization, and performance. The comparison demonstrates that the device in this submission is identical in design, materials, indications, performance and sterilization to the predicate Adaptain FastWrap™ (K122561).
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 874.3620 Ear, nose, and throat synthetic polymer material.
(a)
Identification. Ear, nose, and throat synthetic polymer material is a device material that is intended to be implanted for use as a space-occupying substance in the reconstructive surgery of the head and neck. The device is used, for example, in augmentation rhinoplasty and in tissue defect closures in the esophagus. The device is shaped and formed by the suregon to conform to the patient's needs. This generic type of device is made of material such as polyamide mesh or foil and porous polyethylene.(b)
Classification. Class II.
0
K132198 1 of 2 Ceremed, Inc. Page 6 - 1 Traditional 510(k) - Adaptain FastWrap™, Envelock ", Page C
VI - 510 (K) SUMMARY
Submitted by:
Chelsea Mitchell Ceremed, Inc. 3643 Lenawee Ave. Los Angeles, California 90016 Tel: (310) 815-2125 Fax: (310) 815-2130
SEP 12013
| Contact Person: | Chelsea Mitchell |
|---|---|
| Date Prepared | July 12, 2013 |
| Common/Usual Name: | Soluble Synthetic Polymer Implant Material |
| Proprietary Name: | Adaptain™, Adaptain FastWrap™, Envelock™, Biowai™ |
| Regulation Number: | 21 CFR 874.3620 |
| Regulation Name: | Ear, nose and throat synthetic polymer material |
| Regulatory Class: | II |
| Product Code: | KHJ |
| Predicate Device: | Ceremed, Inc. |
| Adaptain FastWrap™, (K122561) |
Description of the device:
Adaptain™ is a water-soluble, wax-like surgical implant material that will adhere to itself utilized directly and a first application of firm pressure. Adaptain " is designed to be utilized directly out of the package. The implant will soften as it is warmed. The surface of the implant becomes lubricious when wet, and the implant does not swell as it dissolves.
Adaptain™ is comprised of a sterile mixture of water-soluble alkylene oxide copolymers (AOC PolymerBlend™) and contains no other additives or colorants. Adaptain is supplied in a number of forms including bars, sticks, granules and sheets of various sizes with weights ranging from 0.5 to 5 grams each.
Adaptain™ is provided sterile by irradiation and must not be resterilized.
1
K132198
2 of 2
Traditional 510(k) -- Adaptain", Adaptain FastWrap", Envelock ", Biowai Page 6 - 2
Intended use:
Adaptain™ is indicated for use as a water-soluble implant material and as a water-soluble space occupying material as an adjunct during the natural healing process.
Substantial equivalence:
The non-clinical evaluations used to determine substantial equi valence included indications, intended use, design, materials, sterilization, and performance. The comparison demonstrates that the device in this submission is identical in design, materials, indications, performance and sterilization to the predicate Adaptain FastWrap™ (K122561).
2
Image /page/2/Picture/0 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo consists of a stylized graphic of an abstract human figure with three flowing lines extending from its arm, enclosed within a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged around the upper half of the circle.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G60 Silver Spring. MD 20993-0002
September 12, 2013
Ceremed, Incorporated Ms. Chelsea Mitchell Vice President, Regulatory Affairs 3643 Lenawec Avenue Los Angeles, California 90016
Re: K132198
Trade/Device Name: Adaptain ", Adaptain FastWrap", Envelock", Biowai" Regulation Number: 21 CFR 874.3620 Regulation Name: Ear, nose, and throat synthetic polymer material Regulatory Class: Class II Product Code: KHJ Dated: July 12. 2013 Received: July 16. 2013
Dear Ms. Mitchell:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device. subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH docs not evaluate information related to contract liability warranties. We remind you: however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 (CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
3
Page 2 - Ms. Chelsea Mitchell
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR, Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson -S
Mark N. Melkerson Acting Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Ceremed, Inc. Traditional 510(k) - Adaptain", Adaptain FastWrap", Envelock ", Page 5 - 1
Y. INDICATIONS FOR USE:
510 (k) Number (if known): K132198
Device Name: Adaptain™, Adaptain FastWrap™, Envelock™, Biowai™
Indications For Use:
Adaptain" is indicated for use as a water-soluble implant material and as a water-soluble space occupying material as an adjunct during the natural healing process.
Prescription Use X (Per 21 CFR 801.109)
OR
Over-The-Counter Use (Optional Format 1-2-96)
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED.)
CONCURRANCE OF CDRH, OFFICE OF DEVICE EVALUATION (ODE)
David Krause -S
(Division Sign-Off) Division of Surgical Devices 510(k) Number: K132198
Division Sign-Off
510(k) Number_